Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Role of Steroid Hormones in the Modulation of Neuroinflammation by Dietary Interventions.
Refining a Web-based goal assessment interview: item reduction based on reliability and predictive validity.
[Treatment and prognosis of neuromyelitis optica(NMO)].
Remyelination in multiple sclerosis: realizing a long-standing challenge.
[Toxic demyelinating neuropathy and leukoencephalopathy in patients who take the slimming products Thermatrim ® and Pura Alegria ®].
Hyaluronidase and Hyaluronan Oligosaccharides Promote Neurological Recovery after Intraventricular Hemorrhage.
3D models of human ERα and ERβ complexed with 5-androsten-3β,17β-diol.
Multiple sclerosis increases the risk of infections resulting in a hospitalization among veterans.
The Montreal Cognitive Assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
Neuroinflammation and demyelination from the point of nitrosative stress as a new target for neuroprotection.
Stem cell therapy in multiple sclerosis: a future perspective.
Paradoxical Effect of Cortistatin Treatment and Its Deficiency on Experimental Autoimmune Encephalomyelitis.
A multicentre prospective study of Guillain-Barre Syndrome in Japan: a focus on the incidence of subtypes.
Bridging network divides: Building capacity to support aging with disability populations through research.
The many faces of impaired bladder emptying.
Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis.
New data confirm high efficacy of Gilenya® in achieving 'no evidence of disease activity (NEDA)' based on four key measures of MS
A Young Woman With Blurred Vision and Distal Paresthesias.
microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases.
Texture Analysis of T2-Weighted MR Images to Assess Acute Inflammation in Brain MS Lesions.
The Effect of Plasma Exchange on the Expression of FOXP3 and RORC2 in Relapsed Multiple Sclerosis Patients.
Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study.
Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression.
[Corticotherapy and suicidal behavior: A case report].
Pages
« first
‹ previous
…
570
571
572
573
574
575
576
577
578
…
next ›
last »